Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000415948 | SCV000493322 | uncertain significance | not provided | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000415948 | SCV001987781 | uncertain significance | not provided | 2021-06-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22353293, 27535533, 24091712, 24816431, 23510774, 25568878, 24102492, 27551684, 26615986) |
Prevention |
RCV004537236 | SCV004102936 | uncertain significance | TWNK-related disorder | 2023-08-14 | criteria provided, single submitter | clinical testing | The TWNK c.1366C>G variant is predicted to result in the amino acid substitution p.Leu456Val. This variant has been reported in the homozygous state in two siblings from a consanguineous family with infantile onset spinocerebellar ataxia (Dündar et al. 2012. PubMed ID: 22353293). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050139 | SCV000082549 | probable-pathogenic | Infantile onset spinocerebellar ataxia | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |